A protein once thought to simply help cancer cells avoid death turns out to do much more. MCL1 actively drives cancer ...

DEM BioPharma, Inc. (DEM Bio), a biopharmaceutical company dedicated to discovering novel targets for solid tumors and ...

Aperture Therapeutics, a biotechnology company pioneering next-generation precision medicines for neurodegenerative diseases, today announced the advancement of its matrix metalloproteinase-9 (MMP9) ...

Scientists have uncovered evidence that two defining features of cancer are driven by the same underlying molecular process. These features include ...